1. United States
2. Ga.
3. Letter

Medicare should provide coverage for weight loss medications for obese patients to improve health outcomes and reduce long-term healthcare costs associated with obesity-related conditions. Obesity increases the risk of chronic diseases like heart disease, stroke, type 2 diabetes and certain cancers. Providing access to FDA-approved weight loss drugs can help obese individuals lose weight and lower their risk of developing these costly and debilitating conditions. Covering these medications aligns with Medicare's goal of promoting preventive care and managing chronic illnesses. It is a smart investment that can enhance quality of life for beneficiaries while relieving strain on the healthcare system.